MIRA INFORM REPORT

 

 

Report Date :           

17.04.2012

 

IDENTIFICATION DETAILS

 

Name :

INTERNATIONAL BUSINESS NETWORKS PTE. LTD.

 

 

Registered Office :

10 Admiralty Street #04-13 North Link Building Singapore 757695

 

 

Country :

Singapore

 

 

Date of Incorporation :

07.01.2011

 

 

Com. Reg. No.:

201100775M

 

 

Legal Form :

Private Limited Exempt Company

 

 

Line of Business :

Trading of Quinine and Quinine derivatives for pharmaceutical and beverage uses

 

 

No. of Employees :

Not Available

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 5,000

 

 

Status :

Small Company 

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

                   (31.12.2011)                  

Current Rating

(31.03.2012)

Singapore

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Contact Points

 

Company Name:

International Business Networks Pte. Ltd.

Supplied Name:

International Business Networks Pte Ltd.

Trading Address:

10 Admiralty Street #04-13 North Link Building Singapore 757695

Supplied Address:

10 Admiralty Street #04-13 North Link Building Singapore 757695

Telephone Number:

+65-68528980

Fax Number:

+65-67534859

E-mail:

sales@intbiznet.com / jenniferlim@intbiznet.com

 

 

Credit Summary

 

Credit Rating:

Maximum credit USD 5,000

Credit Opinion:

Business connections are permissible.

 

 

Company Identification Details

 

Registered Name:

International Business Networks Pte. Ltd.

Registered Address:

10 Admiralty Street #04-13 North Link Building Singapore 757695

Date of Registration::

2011-1-7

Registered Number:

201100775M

Country of Incorporation:

Singapore

Registered Capital:

SGD 200,000.00 (USD 160,233)

(As of 2012.4, 1 SGD = 0.80117 USD)

Paid-up Capital:

SGD 200,000.00 (USD 160,233) = 200,000 Shares@1 SGD

Legal Form:

Private Limited Exempt Company

Principal Activities:

Trading of Quinine and Quinine derivatives for pharmaceutical and beverage uses.

Staff:

N/A

Status:

Live Company

Listed at Stock Exchange:

No.

Date of Last Annual Return:

N/A

 

Note:

Information on staff number is not available from subject or other source.

 

 

History

 

Subject was incorporated on 2011-1-7 with registered number 201100775M as Private Limited Exempt Company in Singapore.

 

 

Shareholders

Unit: SGD

Name

Subscription Amount

Proportion of Investment (%)

PREMARAJAN PONNAMBATH

200,000

100%

Total

200,000

100%

 

Major Shareholder Information:

1

Name:

PREMARAJAN PONNAMBATH

ID Number:

S2636924Z

Address:

65 ROSEWOOD DRIVE #01-21 ROSEWOOD SUITES Singapore 737875

Nationality:

Singapore P.R.

 

 

Subsidiaries & Branches

 

Subject did not register any subsidiaries or branches, from other source we can not obtain the relevant information, either.

 

 

Manage Information

 

Core Management

Detailed Information of Management:

1

Name:

PREMARAJAN PONNAMBATH

Position:

Director

ID Number:

S2636924Z

Address:

65 Rosewood Drive #01-21 Rosewood Suites Singapore 737875

Nationality:

Singapore P.R.

Date of Appointment:

2011-1-7

2

Name:

LIM SIEW LEE

Position:

Director/ Secretary

ID Number:

S7473571A

Address:

65 Rosewood Drive #01-21 Rosewood Suites Singapore 737875

Nationality:

Singapore P.R.

Date of Appointment:

2011-1-7

 

 

Operation Information

 

Offices & Factories

 

Office

Address:

10 Admiralty Street #04-13 North Link Building Singapore 757695

 

Production Information

l         Subject is a trader of quinine and quinine products without any production activities

 

Purchase

l         The productions are mostly purchased from abroad.

 

Sales Information

l         Subject is mainly engaged in trading of quinine and quinine products.

l         Subject introduced that it is an agent in Asia for PT. Sinkona Indonesia Lestari.

l         PT. Sinkona Indonesia Lestari is a world manufacturer in Quinine and Quinine derivatives production, and located in Indonesia.

l         Subject introduced that its major products sold as following:

 

Product

1

Quinine Base

2

Quinidine Base

3

Quinine Hydrochloride

4

Quinine Dihydrochloride

5

Quinine Sulphate

6

Cinchonine

7

Cinchonidine

8

Quinine Bisulphate

9

Quinine Benzoate

10

Quinidine Bisulphate

11

Quinidine Gluconate

l         Subject introduced that the Minimum Order Quantity is 25Kgs.

l         At present, its selling territory mainly covers Asia, and subject will spread the selling territory to all over the world.

 

 

Settlements

 

Subject introduced that at present, the settlements of subject are TT in advance and L/C, but subject declined to disclose more details information about it.

 

 

Financial Information

 

In Singapore, Limited Exempt Private Companies are not obligated to submit their financial statements to the local registry. The subject also declined to disclose such information due to the confidentiality reason.

 

 

Bankers

 

Open Account Bank

The bankers’ information is not available from the subject or other sources.

 

 

Interview Details

 

Name:

Ms. Lim

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.66

UK Pound

1

Rs.81.80

Euro

1

Rs.67.18

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.